当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析

人福医药

(600079)

  

流通市值:287.65亿  总市值:304.25亿
流通股本:15.43亿   总股本:16.32亿

人福医药(600079)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润21.83亿元,每股收益1.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2190076.92万元,未分配利润1075454.95万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3682418.70万元,负债1492341.78万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入17,883,352,478.3412,063,918,105.776,137,399,886.0525,435,484,349.43
营业总成本15,280,234,823.4510,297,053,275.115,336,905,257.7922,665,868,260.22
其他经营收益
营业利润2,698,777,025.771,834,513,499.07857,303,978.422,522,028,572
利润总额2,631,660,616.271,789,225,532.9827,442,675.242,422,830,341.45
净利润2,183,121,693.471,497,174,002.51698,615,043.071,778,342,930.44
每股收益
其他综合收益130,814,456.6287,566,822.09-26,945,270.08132,562,352.95
综合收益总额2,313,936,150.091,584,740,824.6671,669,772.991,910,905,283.39
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计19,983,623,102.4120,737,585,191.420,412,196,364.8319,858,374,856.88
非流动资产:
非流动资产合计16,840,563,927.7116,817,549,830.0116,754,349,681.8216,649,949,124.87
资产总计36,824,187,030.1237,555,135,021.4137,166,546,046.6536,508,323,981.75
流动负债:
流动负债合计11,830,855,089.9413,458,395,710.8813,663,997,789.8113,339,976,221.94
非流动负债:
非流动负债合计3,092,562,733.92,690,194,630.092,166,083,875.672,475,288,773.31
负债合计14,923,417,823.8416,148,590,340.9715,830,081,665.4815,815,264,995.25
所有者权益(或股东权益):
归属于母公司股东权益合计18,913,741,270.3618,335,044,814.1318,134,575,571.2117,623,818,879.08
股东权益合计21,900,769,206.2821,406,544,680.4421,336,464,381.1720,693,058,986.5
负债和股东权益合计36,824,187,030.1237,555,135,021.4137,166,546,046.6536,508,323,981.75
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计17,546,070,089.5311,632,352,871.45,447,617,031.7324,697,293,034.17
经营活动现金流出小计15,898,115,269.5610,773,961,034.175,784,396,672.3622,533,027,974.68
经营活动产生的现金流量净额1,647,954,819.97858,391,837.23-336,779,640.632,164,265,059.49
投资活动产生的现金流量:
投资活动现金流入小计300,448,840.44117,970,742.179,230,501.69482,937,224.92
投资活动现金流出小计673,451,891.95425,795,199.61249,050,876.061,224,962,331.99
投资活动产生的现金流量净额-373,003,051.51-307,824,457.44-239,820,374.37-742,025,107.07
筹资活动产生的现金流量:
筹资活动现金流入小计8,541,276,648.595,414,015,255.552,335,229,393.439,860,935,168.7
筹资活动现金流出小计9,995,521,691.015,508,718,869.412,154,055,389.2911,358,932,530.73
筹资活动产生的现金流量净额-1,454,245,042.42-94,703,613.86181,174,004.14-1,497,997,362.03
汇率变动对现金及现金等价物的影响9,555,984.2114,449,373.586,805,021.75-23,866,875.3
现金及现金等价物净增加额-169,737,289.75470,313,139.51-388,620,989.11-99,624,284.91
期末现金及现金等价物余额2,721,082,968.513,361,133,397.772,502,199,269.152,890,820,258.26
补充资料:
现金及现金等价物的净增加额-470,313,139.51--99,624,284.91
最新报告期:2025-11-04
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋张懿,谭紫媚1.281.371.472025-11-04
首创证券王斌1.191.451.742025-09-25
TOP↑